North American STD diagnostics market is growing at a CAGR of around 8.2% during the forecast period. North America is considered to be the dominating country due to various factors such as R&D, high healthcare expenditure, rising number of STD patients. North America has one of the strongest economies globally, as it comprises more than 27.8% of the world’s economy as per World Economic Forum. North American STD diagnostics market comprises two countries including the US and Canada. North America spends almost 17.20% of GDP on healthcare expenditure, whereas Canada spends 10.60% of GDP on healthcare. Accordingly, the expenditure rate of the US is more than Canada, as the country invests more on R&D and there are ample of opportunities. The major factors that are driving the North American STD diagnostics market include rising healthcare spending, R&D investments, high quality of healthcare infrastructure, demand for treatment and care and other factors.

Visit for Global Sexually Transmitted Diseases (STD) Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size

Further, the presence of the key players such as Abbott Laboratories, Inc., Becton, Dickinson and Co., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific, Inc. among others are also affecting the North American STD diagnostics market. The STD diagnostics key players are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment. 

For instance, In January 2018, Bio-Rad announced that it received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for the IH-Incubator L and IH-Centrifuge L instruments to be used with the full range of Bio-Rad’s IH-System Gel Reagents for manual blood typing methods. Whereas, in july, 2017 BIOMERIEUX has received 510(k) clearances from FDA for enhanced pathogen detection capability on VITEK MS. The VITEK MS system’s newly expanded database and Mycobacterium/Nocardia and Moulds reagent kits in the US.

Research Methodology

The market study of the North American STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American STD Diagnostics Market Research and Analysis by Disease Type
2. North American STD Diagnostics Market Research and Analysis by Product
3. North American STD Diagnostics Market Research and Analysis by End-user

The Report Covers

• Comprehensive research methodology of the North American STD Diagnostics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American STD Diagnostics market.
• Insights about market determinants which are stimulating the North American STD Diagnostics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.